Primaa Integrates Cleo Skin AI with PathPresenter IMS
Cleo Skin is the first AI tool worldwide for dermatopathology, designed to assist pathologists in diagnosing melanoma, naevus, squamous cell carcinoma, and basal cell carcinoma from digitized histology slides
- By providing AI-assisted classifications, Cleo Skin helps streamline pathologists’ workflows, enhancing diagnostic accuracy and supporting better patient outcomes.
- Integration with PathPresenter’s platform makes Cleo Skin available to a wider audience of pathologists worldwide.
- Live demos of Cleo Skin integrated into PathPresenter will be given at ASDP 2025, showcasing the tool’s capabilities in a practical setting.
Transforming Dermatopathology with AI
Paris, FRANCE and Montville, NJ, USA — 6 November 2025 — Primaa and PathPresenter announce the integration of Primaa’s flagship AI solution, Cleo Skin, with PathPresenter’s FDA 510(k) and CE-IVDR cleared clinical viewer and IMS platform. This partnership, combining the analytical power of Primaa’s model with the reach of PathPresenter’s platform, provides an expanded audience of pathologists with a unique opportunity to enhance both the accuracy and efficiency of skin cancer diagnosis.
“Our mission has always been to empower pathologists with AI tools that make their work faster, more precise, and more reliable. With Cleo Skin now integrated with PathPresenter more pathologists can experience firsthand how AI can transform dermatopathology practice, improving both workflow and patient outcomes.” explains Fanny Sockeel, CEO and co-founder of Primaa.
Cleo Skin is the first AI tool worldwide designed specifically to assist in diagnosing the three most common skin cancers: melanoma, squamous cell carcinoma, and basal cell carcinoma. By analyzing digitized histology slides, the tool highlights areas of interest and provides AI-assisted classifications, helping pathologists make faster and more consistent decisions.
“We’re thrilled to partner with Primaa in bringing Cleo Skin to the PathPresenter platform,” said Dr. Cory Batenchuk, SVP of Operations and co-founder of PathPresenter. “By integrating Primaa’s groundbreaking AI with our IMS, we’re empowering pathologists worldwide with more tools that enhance diagnostic accuracy and improve clinical outcomes. This collaboration, including our support for Primaa’s current clinical validation study, reflects our shared commitment to advancing the practice of pathology through innovation and accessibility.”
Primaa and PathPresenter will demonstrate the integration live at the ASDP 2025 conference in Baltimore, November 6-9. We welcome everyone to visit us at the show for the opportunity to explore Cleo Skin on the platform and see its real-world applications in a safe, controlled environment, and experience the tangible benefits of AI in everyday dermatopathology practice.
Members of the College of American Pathologists can also test and explore Cleo Skin in a safe, hands-on environment through CAP’s interactive AI studio (aistudio.cap.org), powered by PathPresenter. Users can interact directly with digitized slides, observe AI outputs, and evaluate how the tool improves diagnostic confidence and workflow efficiency.
Clinical Validation and Educational Impact
Looking ahead, Primaa will share results from its ongoing clinical validation study in the United States, with updates expected at USCAP 2026. This study underscores Primaa’s commitment to rigorous clinical validation and the adoption of AI-powered solutions by leading pathology institutions.
By integrating Cleo Skin on PathPresenter, Primaa empowers pathologists to experience firsthand the capabilities of AI in dermatopathology, enabling faster, more accurate, and more consistent diagnoses while supporting improved patient outcomes.
About Primaa
Primaa is a leading provider of integrated AI solutions dedicated to enhance the accuracy and efficiency of biomarker detection in dermatopathology and breast pathology. Its flagship tools, Cleo Breast and Cleo Skin, support pathologists in delivering faster and more reliable diagnoses, ultimately redefining how tissue lesions are assessed. Learn more at www.primaa.com.
About PathPresenter
PathPresenter is an enterprise-grade digital pathology platform designed by pathologists for pathologists. It provides a vendor-neutral image management and workflow solution supporting clinical diagnosis, remote consultation, education, and research. Its Clinical Viewer has earned FDA 510(k) clearance and CE-IVDR certification for primary diagnosis in approved configurations. By enabling integration with best-in-class AI tools and fostering interoperability, PathPresenter helps laboratories adopt advanced digital pathology workflows confidently and efficiently. Learn more at www.pathpresenter.com.
Media Contacts
Perrine Salembier: perrine@primaalab.com
Neil Humphrey: neil@pathpresenter.com
More Posts
- “Into the Pathoverse” webinar now available on-demand
- Primaa Integrates Cleo Skin AI with PathPresenter IMS
- Pathology’s Goldmine: Use it or Lose it
- PathPresenter Achieves CE Mark for IVDR Compliance with Digital Pathology Clinical Viewer
- Voicebrook and PathPresenter Partner to Bring Speech-Enabled Reporting to Digital Pathology